Existing investor FoxKiser has returned for a $32.5m round that follows the cancer immunotherapy T cell developer's series A two years ago.

Stealth has secured $100m in convertible note financing across two rounds, one of which was led by Nan Fung Technology's Pivotal Beta.

Existing investors New York Life and UBS came back for a series E round that increased the wealth management platform's total funding to $120m.

Decibel Therapeutics, which is developing drugs to combat hearing loss, raised the cash in a round that included SR One, Regeneron and GV.

The endpoint security software producer, which counts Citi, Capital One, Dell and TenEleven as investors, has now raised almost $300m in total.

Raiffeisen and Uniqa have contributed to a fund that will help the firm expand from seed-stage deals to series A and B rounds.

CapitalG returned for a round that boosted the endpoint protection platform's overall funding to more than $480m, valuing it at more than $3bn.

Paytm has paid an undisclosed amount for the AI technology developer, which raised $7.7m in a Flipkart-backed round in 2015.

Intel Capital, which had previously backed the Amazon and Sony-backed companion robot developer in 2016, also took part in its latest round.